![]() ![]() NEPTIS® was the first synthesizer to receive the US, European and Japanese approval for a proprietary tracer used in the Alzheimer disease detection (Amyvid, Florbetapir). Gradually, NEPTIS® synthesizers were approved worldwide by many drug agencies. This new combination offered then the capability of creating an unlimited number of individualized radiotracer synthesis applications. In 2009, the NEPTIS® project was started based on the long experience in radiotracers production in GMP environment and became the combination of a multi-purpose PET synthesizer and an advanced software system meeting the latest GMP requirements.
0 Comments
Leave a Reply. |